22nd Century Group (XXII) Falls Following FDA Feedback on Very Low Nicotine MRTPA Filings
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 4/19/2025
- Wall Street choppy as Eli Lilly jumps, UnitedHealth plummets
- Trump criticizes Fed's Powell, says termination cannot come fast enough
- UnitedHealth shares tumble 20% on annual earnings forecast cut, soft Q1 results
- TSMC dismisses Intel rumors, says in no talks to form JV
- Eli Lilly shares jump 12% on positive Phase 3 results for oral diabetes drug
- Hewlett Packard Enterprise (HPE) Board To Discuss Whether To Replace CEO - Semafor
- Investment commitments in U.S. nears $3 trillion since Trump took office
- Japan's core inflation accelerates, complicating BOJ's rate path
- Bumble under pressure from activist Randian Capital to sell itself
- Morgan Stanley favors these 6 restaurant and food stocks as growth slows
- After-hours movers: Netflix, Roku, Hertz
- After-hours movers: United Airlines, Interactive Brokers, J.B. Hunt Transport Services
- After-hours movers: Broadcom, Levi, Human and more
- After-hours movers: nCino, Newsmax, Waton Financial
- After-hours movers: PVH Corp., Progress Software Corporation, Live Nation
FDA Provides Positive and Encouraging Feedback for 22nd Century’s Very Low Nicotine MRTPA Filings
January 5, 2017 9:15 AM EST22nd Century Seeking Approval to Market the Worlds Lowest Nicotine Tobacco Cigarettes
CLARENCE, N.Y.--(BUSINESS WIRE)-- 22nd Century Group, Inc. (NYSE MKT:XXII), a plant biotechnology company that is focused on reducing the harm caused by smoking, today announced that the U.S. Food and Drug Administration (FDA) has provided the Company with helpful and positive feedback on the Companys combined... More
